<?xml version="1.0"?>
<rss version="2.0">
   <channel>
      <title>Chapter 33 Connective Tissue Disorders by </title>
      <link>https://padlet.com/knewton5952/sgsyymmki3c0</link>
      <description>Amy Stein and Kendra Newton</description>
      <language>en-us</language>
      <pubDate>2017-09-08 00:00:02 UTC</pubDate>
      <lastBuildDate>2023-09-22 23:04:43 UTC</lastBuildDate>
      <webMaster>hello@padlet.com</webMaster>
      <image>
         <url></url>
      </image>
      <item>
         <title>           Anti Rheumatic</title>
         <author>knewton5952</author>
         <link>https://padlet.com/knewton5952/sgsyymmki3c0/wish/185726544</link>
         <description><![CDATA[<div>Chronic disorder with autoimmune (body's immune system attacks healthy cells) and inflammatory components. <br><br><strong><em>Medications commonly used to treat Rheumatoid Arthritis</em></strong><strong><del>:</del></strong><br><br><strong>Disease-Modifying Antirheumatic Drugs (DMARDs)<br>DMARDs 1:Major Nonbiologic DMARDs<br>Immunomodulator Meds:</strong><br><strong>Prototype:</strong> <br>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;Methotrexate <br>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;<br><strong>DMARDs 2: Major Biologic Dmards<br><br>DMARDs 3: Minor Nonbiologic  DMARDs<br></strong><br><strong>Action</strong>- slow joint degeneration and progression of RA<br><br><strong>Glucocorticoids</strong><br><strong>Prototype</strong>: Prednisone<br>Action- provide symptomatic relief of inflammation and pain<br><br><strong>NSAIDs</strong><br><strong>Prototype</strong>: Aspirin<br><br><strong>Action</strong>- provide rapid, symptomatic relief of inflammation and pain<br><br><strong>Complications/nursing considerations:<br><br>&nbsp;Methotrexate</strong><br>- Increased risk of infection<br><em>(advise pt to notify Dr immediately)</em><br>- Hepatic fibrosis and toxicity<br><em>(monitor liver function test, observe for anorexia, abdominal fullness, and jaundice)</em><br>- Bone marrow suppression<br><em>(obtain baseline CBC, include platelet count; repeat every 3-6 months)</em><br>- Ulcerative stomatitis<br><em>(inspect mouth, gums, and throat daily; advise pt to take meds with food or water; stop meds if symptoms occur)</em><br>- Fetal death/congenital abnormalities<br>(<em>avoid use during pregnancy; use adequate contraception while taking meds)</em><br><br><strong>Prednisone</strong><br>- Risk of infection<br><em>(notify dr immediately if symptoms occur)<br>- osteoporosis</em><br><em>(take with calcium supplements</em>)<br>- Adrenal suppression<br><em>(notify dr immediately if manifestations occur)</em><br>- Fluid retention<br><em>(monitor for signs of fluid excess-crackles, weight gain, edema)</em><br>- GI discomfort<br>(<em>advise client to report symptoms of GI bleeding)</em><br>- Hyerpglycemia<br><em>(monitor blood glucose levels)</em><br>- Hypokalemia<br>(monitor serum potassium <em>levels; tell pt to eat potassium rich foods or take potassium supplement)<br><br></em><strong><em>Contraindications: <br><br>Methotrexate:<br>-</em></strong><em>pregnancy risk X</em><strong><em><br></em></strong><em>- liver failure <br>- alcohol use disorder<br>-use with caution with liver or kidney dysfunction, cancer, suppressed bone marrow function<br>- peptic ulcer disease<br>- ulcerative colitis<br>- use cautiously with children or women who are breastfeeding</em><strong><em><br><br>Prednisone:<br></em></strong><em>-systemic fungal infections<br>-live virus vaccines<br>- warn clients against abrupt discontinuation</em><strong><em><br><br>Administration<br></em></strong><em>-advise patient that effects of DMARDs are delayed and it may take 3-6 weeks, with full therapeutic effect taking months<br>-glucocorticoids can be used as oral agents or as intra-articular injections<br>-short term therapy can be used to control exacerbations of symptoms or while waiting for effects of DMARDs to develop.&nbsp;</em></div>]]></description>
         <enclosure url="" />
         <pubDate>2017-09-08 00:04:21 UTC</pubDate>
         <guid>https://padlet.com/knewton5952/sgsyymmki3c0/wish/185726544</guid>
      </item>
      <item>
         <title>                 Anti Gout</title>
         <author>knewton5952</author>
         <link>https://padlet.com/knewton5952/sgsyymmki3c0/wish/185726788</link>
         <description><![CDATA[<div>(aka gouty arthritis) Painful type of arthritis that is caused by elevated levels of uric acid, which can accumulate and cause localized inflammation in synovial areas.<br><br><strong><em>Medications commonly used to treat Gout:</em></strong><br><br><strong>Anti-Inflammatory Agents:<br><br></strong><strong><em>Prototype</em></strong>: Colchicine<br>-once the drug of choice, but now only used to treat patients who do not respond to safer treatments.<br><br><strong>Action:</strong> decrease inflammation relating to gout<br> <br><strong>Complications/nursing considerations:<br></strong> Mild GI distress, which can progress to GI toxicity<br>( take oral meds with food; take antidiarrheal agents as prescribed; notify provider if distress occurs)<br><br><strong>Agents for Hyperuricemia<br></strong><br><strong><em>Prototype:</em></strong><em> </em>Allopurinol<br><br><strong>Action:</strong> inhibit uric acid production<br><br><strong>Complications: <br>-</strong>fever, rash, kidney and liver damage<br>( if administering IV, stop infusion- severe reaction can require&nbsp; hemodialysis or glucocorticoids) <br>- kidney injury<br>(encourage 2-3 liters of fluids/daily; monitor I&amp;O, BUN, Creatinine)<br>-Hepatitis<br>(monitor liver enzymes)<br>- GI distress<br>(administer with food)<br>- Increase in gout attacks<br>(instruct pt to report attacks to provider)<br><br><strong>Administration:<br></strong>- monitor uric acid levels, CBC, urinalysis, and liver and kidney function test<br>-advise patient to take with food or after meals to minimize GI distress<br>- instruct patients to concurrently take preventive measures, such as avoid alcohol and foods high in purine (red meat, scallops)<strong><br><br>Colchicine</strong>- oral <br><br><strong>Allopurinol</strong>- IV ( well diluted and administered over 30-60 minutes)<br><br><br><strong>EBP Journal:</strong><br><a href="https://mospace.umsystem.edu/xmlui/bitstream/handle/10355/61288/EBPJune2017pE01.pdf?sequence=1">https://mospace.umsystem.edu/xmlui/bitstream/handle/10355/61288/EBPJune2017pE01.pdf?sequence=1</a></div>]]></description>
         <enclosure url="" />
         <pubDate>2017-09-08 00:06:39 UTC</pubDate>
         <guid>https://padlet.com/knewton5952/sgsyymmki3c0/wish/185726788</guid>
      </item>
      <item>
         <title>Systemic Lupus                 Erythematosus </title>
         <author>knewton5952</author>
         <link>https://padlet.com/knewton5952/sgsyymmki3c0/wish/185726891</link>
         <description><![CDATA[<div>Autoimmune condition that can cause damage to joints, skin, blood vessels, and organs.<br><br><strong><em>Medications commonly used to treat SLE:<br><br>Monoclonal Antibody Medication<br>Prototype</em></strong><em>: </em>Belimumab<br><br><strong>Action</strong>: Disrupts activation of B-lymphocytes through interference with BLyS, a protein needed for B-cell activation <br><br><strong>Complications/nursing considerations:</strong><br>- GI Effects (nausea, vomiting, diarrhea)<br>(advise pt to take natural GI remedies such as ginger, tea, or hard candy)<br>- Headache, depressed mood<br>(notify provider immediately if feeling suicidal thoughts)<br>- Insomnia<br>(teach pt how to promote adequate sleep- quiet, dark, relaxing bedroom; no eating before bed; no exercising before bed)<br>-Infusion reaction<br>(infuse slowing over an hour; medication might be prescribed to minimize reaction)<br>- Increased risk for infection<br>(avoid being around sick people; no live vaccines within 30 days of medication; notify provider if fever, painful urination, or bloody diarrhea is present)<br><br><strong>Contraindications:</strong><br>- Pregnancy risk C<br>- Avoid breastfeeding<br>- severe renal impairment<br>- SLE effecting CNS<br>- caution in older adults <br>- caution in clients with depression, cardiac disorders, or infections<strong><em><br><br><br>Administration:<br>-</em></strong>reconstitute with sterile water, and dilute with only 0.9% normal saline<br>-refrigerate solution no longer than 8 hours after reconstitution (allow solution to stand in room temp for 10-15 mins prior to use)<br>-administered via IV infusion, and given slowly over the course of an hour (monitor closely for infusion reactions and hypersensitivity)<br>-discard unused solution<br>-no administration of live virus vaccines within 30 days</div>]]></description>
         <enclosure url="" />
         <pubDate>2017-09-08 00:07:10 UTC</pubDate>
         <guid>https://padlet.com/knewton5952/sgsyymmki3c0/wish/185726891</guid>
      </item>
      <item>
         <title>            Fibromyalgia</title>
         <author>knewton5952</author>
         <link>https://padlet.com/knewton5952/sgsyymmki3c0/wish/185726952</link>
         <description><![CDATA[<div>Syndrome characterized by muscle pain and fatigue.<br><br><strong><em>Medications commonly used to treat Fibromyalgia:<br><br></em></strong><strong>Serotonin-Norepinephrine Reuptake Inhibitors:</strong><strong><em><br>Prototypes: <br>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; </em></strong>Duloxetine<br>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; Milnacipran<br><br><strong>Action-</strong> Restores balance of neurotransmitters, serotonin, and norepinephrine<br><br><strong>Gamma-Aminobutyric Acid Analogue (GABA)<br>PROTOTYPE</strong>: PREGABALIN<br><br><strong>Action</strong>- binds to alpha-2-delta in CNS tissue <br><br><strong>Complications/nursing considerations:</strong><br>-Drowsiness, dizziness, blurred vison<br>(instruct patient not to drive or operate heavy machinery; change positions slowly, fall prevention strategies)<br>- Nausea, anorexia, weight loss<br>(monitor weight and food intake)<br>- headache, insomnia, anxiety<br>- Withdrawal syndrome -"headaches, nausea, visual disturbances, anxiety, dizziness, tremors"<br>(instruct pt to withdrawal from med gradually)<br>-Sexual dysfunction<br>(report sexual dysfunction to provider) <br><strong>(GABA)</strong>- increased appetite, weight gain, constipation, abdominal pain&nbsp; (patient teaching on ways to prevent weight gain)<br>-Rhabdomyolysis (acute onset of&nbsp; severe muscle weakness and tenderness with elevation in serum creatinine kinase)<br>-(notify provider immediately)<br><br><br><strong>Contraindications:</strong><br><br>-Pregnancy Risk C<br>- hepatic or renal impairment<br>-MAOI within 14 days<br>-caution with patients with cardiac problems, hypertension, diabetes, GI disorders, and glaucoma<br><br><strong>Administration:</strong><br>-orally, no regard to food; swallow whole; taper withdrawal gradually over 2 weeks<br><br><br><br></div>]]></description>
         <enclosure url="" />
         <pubDate>2017-09-08 00:07:45 UTC</pubDate>
         <guid>https://padlet.com/knewton5952/sgsyymmki3c0/wish/185726952</guid>
      </item>
      <item>
         <title>RA Commercial</title>
         <author>knewton5952</author>
         <link>https://padlet.com/knewton5952/sgsyymmki3c0/wish/185730563</link>
         <description><![CDATA[<div><a href="https://youtu.be/jgx8dIyP67g">https://youtu.be/jgx8dIyP67g</a><br><br><strong>Actemra:</strong><br><a href="https://www.youtube.com/watch?v=YaARULpYzis">https://www.youtube.com/watch?v=YaARULpYzis</a><br><br><a href="https://www.youtube.com/watch?v=Bk5uyjPXMlo">https://www.youtube.com/watch?v=Bk5uyjPXMlo</a><br><br></div>]]></description>
         <enclosure url="" />
         <pubDate>2017-09-08 00:34:20 UTC</pubDate>
         <guid>https://padlet.com/knewton5952/sgsyymmki3c0/wish/185730563</guid>
      </item>
      <item>
         <title>chapter 34 Bone Disorders</title>
         <author>knewton5952</author>
         <link>https://padlet.com/knewton5952/sgsyymmki3c0/wish/186842317</link>
         <description><![CDATA[<div><a href="https://padlet.com/amy_stein/m495vuhpwp88">https://padlet.com/amy_stein/m495vuhpwp88</a><br><br></div>]]></description>
         <enclosure url="" />
         <pubDate>2017-09-12 15:53:14 UTC</pubDate>
         <guid>https://padlet.com/knewton5952/sgsyymmki3c0/wish/186842317</guid>
      </item>
      <item>
         <title>Case Study</title>
         <author>knewton5952</author>
         <link>https://padlet.com/knewton5952/sgsyymmki3c0/wish/186925891</link>
         <description><![CDATA[]]></description>
         <enclosure url="https://padletuploads.blob.core.windows.net/prod/218447992/467113e66887b324a95ea2c961bb3e45/Case_Study__RA.docx" />
         <pubDate>2017-09-12 18:34:33 UTC</pubDate>
         <guid>https://padlet.com/knewton5952/sgsyymmki3c0/wish/186925891</guid>
      </item>
      <item>
         <title>References:</title>
         <author>knewton5952</author>
         <link>https://padlet.com/knewton5952/sgsyymmki3c0/wish/186931782</link>
         <description><![CDATA[<div><br><br></div>]]></description>
         <enclosure url="https://padletuploads.blob.core.windows.net/prod/218455069/343139793ded7cc44e97c6ec2372d8a5/Bibliography.docx" />
         <pubDate>2017-09-12 18:45:22 UTC</pubDate>
         <guid>https://padlet.com/knewton5952/sgsyymmki3c0/wish/186931782</guid>
      </item>
      <item>
         <title>Journal Entry</title>
         <author>amy_stein</author>
         <link>https://padlet.com/knewton5952/sgsyymmki3c0/wish/186936013</link>
         <description><![CDATA[]]></description>
         <enclosure url="https://padletuploads.blob.core.windows.net/prod/218455069/680e7955926d0f4ca270135633e9e1ab/An_Evaluation_of_Rituximab_for_Rheumatoid_22.pdf" />
         <pubDate>2017-09-12 18:53:32 UTC</pubDate>
         <guid>https://padlet.com/knewton5952/sgsyymmki3c0/wish/186936013</guid>
      </item>
      <item>
         <title>Source Article</title>
         <author>amy_stein</author>
         <link>https://padlet.com/knewton5952/sgsyymmki3c0/wish/186937368</link>
         <description><![CDATA[<div><a href="https://www.uptodate.com/contents/rituximab-and-other-b-cell-targeted-therapies-for-rheumatoid-arthritis">https://www.uptodate.com/contents/rituximab-and-other-b-cell-targeted-therapies-for-rheumatoid-arthritis</a></div>]]></description>
         <enclosure url="" />
         <pubDate>2017-09-12 18:56:47 UTC</pubDate>
         <guid>https://padlet.com/knewton5952/sgsyymmki3c0/wish/186937368</guid>
      </item>
   </channel>
</rss>
